ArticleHemaSphere2022

Chimeric Antigen Receptor T-cell Therapy in Hematologic Malignancies and Patient-reported Outcomes: A Scoping Review.

Fabio Efficace et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.